AMNIOX® Medical Announces Initiation of Prospective, Randomized, Controlled Clinical Study of Chronic Wounds

Amniox Medical, Inc., a developer and marketer of restorative therapies processed from amniotic membrane and umbilical cord, announces the initiation of a randomized, controlled clinical trial of its proprietary product in patients with chronic wounds.



from Content Keyword RSS http://ift.tt/1tW5qtC

via IFTTT